Kanoria Chemicals & Industries Limited (BOM:506525)
India · Delayed Price · Currency is INR 89.50
+0.19 (0.21%)
At close: Aug 1, 2025
Sage Therapeutics Revenue
In the fiscal year ending March 31, 2025, Kanoria Chemicals & Industries had annual revenue of 15.37B INR with 4.06% growth. Kanoria Chemicals & Industries had revenue of 4.31B in the quarter ending March 31, 2025, with 19.26% growth.
Revenue
15.37B
Revenue Growth
+4.06%
P/S Ratio
0.25
Revenue / Employee
40.23M
Employees
382
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15.37B | 599.89M | 4.06% |
| Mar 31, 2024 | 14.77B | -1.02B | -6.44% |
| Mar 31, 2023 | 15.78B | 2.09B | 15.29% |
| Mar 31, 2022 | 13.69B | 2.74B | 25.05% |
| Mar 31, 2021 | 10.95B | 901.56M | 8.97% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |